Deltagen to Open Facility in France, Eyes Stronger European Presence | GenomeWeb

NEW YORK, Sept. 27 - A wholly owned subsidiary of Deltagen will create a new research and development center in Strasbourg, France, in a move designed to strengthen the company’s research presence on the continent, Deltagen said on Thursday. 

The unit, Deltagen Europe, said it chose the new location because of its proximity to the Institut de Genetique et de Biologie Moleculaire et Cellulaire, with which Deltagen has a “close research partnership.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.